发明名称 PYRAZINAMIDE COMPOUND
摘要 <p>Disclosed is a pyrazinamide compound represented by the formula (1), a tautomer, stereoisomer or pharmaceutically acceptable salt thereof, or a solvate of the compound or the tautomer, stereoisomer or pharmaceutically acceptable salt thereof, which has an excellent GK-activating activity and is therefore useful as a medicinal agent. (1) wherein R 1 represents a hydrogen atom, a C 1-8 alkyl group, a C 3-8 cycloalkyl group, a C 2-9 heterocyclyl group, a phenyl group, a C 1-9 heteroaryl group, a C 7-14 arylalkyl group or the like; R 2 represents a C 1-8 alkyl group, a C 2-9 heterocyclyl group, a phenyl group, a C 1-9 heteroaryl group or the like; Ar represents a monocyclic or fused polycyclic C 1-9 heteroaryl group represented by the formula (2) or a C 2-9 heterocyclyl group represented by formula (2); Y represents -S-, -O-or -NH-; and Z represents -S-, -O- or -CH 2 -.</p>
申请公布号 EP2157090(A1) 申请公布日期 2010.02.24
申请号 EP20080765775 申请日期 2008.06.20
申请人 TAISHO PHARMACEUTICAL CO. LTD.;NISSAN CHEMICAL INDUSTRIES, LTD. 发明人 UMEMIYA, HIROKI;WATATANI, KENGO;KAWAGUCHI, TAKANORI;KAWABE, KENICHI;OKADA, TAKUMI;SASAKO, SHIGETADA;SAITO, NORIKO
分类号 C07D403/12;A61K31/497;A61K31/501;A61P3/04;A61P3/10;A61P43/00;C07D401/14;C07D403/14;C07D413/14;C07D417/14 主分类号 C07D403/12
代理机构 代理人
主权项
地址